SCHEMBL7094874

SCHEMBL7094874

O=[N+]([O-])c1cccc(Cn2cccn2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.56
TSHR P16473 3/20 0.51
KMT2A Q03164 3/20 0.51
MEN1 O00255 2/20 0.51
HPGD P15428 2/20 0.49
ALDH1A1 P00352 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
POLB P06746 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
MAPT P10636 1/20 0.48
KDM4E B2RXH2 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PDE4B Q07343 1/20 0.47
NOX4 Q9NPH5 1/20 0.47
KCNN3 Q9UGI6 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30000671 1.00 HTT (0.56) HTTTSHRKMT2AMEN1HPGD
SCHEMBL28599642 0.91 KMT2A (0.53) HTTTSHRKMT2AMEN1HPGD
Methanesulfonic Acid Methyl Ester SCHEMBL23529684 0.90 HTT (0.47) HTTTSHRKMT2AMEN1HPGD
Methyl Alcohol SCHEMBL23529686 0.90 KMT2A (0.52) HTTTSHRKMT2AMEN1HPGD
SCHEMBL7094207 0.83 CYP19A1 (0.55) HTTKMT2AMEN1POLBMAPT
SCHEMBL4319471 0.82 PDE4B (0.47) HTTKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL8802059 0.81 CYP19A1 (0.55) HTTTSHRKMT2AMEN1HPGD
SCHEMBL14256403 0.81 HTT (0.68) HTTTSHRKMT2AMEN1HPGD
SCHEMBL8802767 0.80 TSHR (0.56) HTTTSHRKMT2AMEN1HPGD
SCHEMBL4754495 0.80 TSHR (0.59) HTTTSHRKMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023227125-A1 NEW FUSED-HETEROCYCLIC COMPOUND AS CDK INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2023-11-30 WO disclosed
CN-113004286-B Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2022-08-12 CN disclosed
CN-113004286-A Tricyclic compounds as plasma kallikrein inhibitors and uses thereof 成都康弘药业集团股份有限公司 2021-06-22 CN disclosed
EP-1349552-A1 PYRAZOLO 3,4-D]PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2003-10-08 EP disclosed
WO-2002055082-A1 PYRAZOLO[3,4-D]PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS VERNALIS RESEARCH LIMITED (GB) 2002-07-18 WO disclosed